RXMD FILINGS Gross Margin DECLINES 8%>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
For the three months ended March 31, 2018, gross profit decreased 8% as compared to the same period in 2017
because of increased DIR fees assessed by PBM’s in 2018 and a decrease in compounding revenues despite a similar
number of claims in each quarter. Total gross profit from compounding claims decreased from approximately
$798,000 in first quarter 2017 to $411,000 in first quarter 2018, a 48% decrease as compared to first quarter 2017.
MUST BE RXMD CEO CONFUSED AGAIN!!!